Queen's University Belfast

Aviceda Therapeutics Announces Formation of Renowned European Clinical Advisory Board

Retrieved on: 
Monday, April 8, 2024
Technology, Research, Nanotechnology, Clinical Trials, Biotechnology, Health, Pharmaceutical, Optical, Science, Faculty, Medical University of Vienna, Part, Patient, Queen's University, Optometry, Queen's University Belfast, CAB, MD, Royal Victoria Hospital, Laborie (company), Medical school, Therapy, Retina, Safety, AMD, Geographic atrophy, Pharmaceutical industry

Aviceda Therapeutics , a private clinical-stage biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic, non-resolving inflammation, announced today the formation of its European Clinical Advisory Board (CAB) made up of top internationally recognized thought leaders in retina to provide strategic consultation on the company’s clinical development of its lead asset, AVD-104, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Key Points: 
  • Aviceda Therapeutics , a private clinical-stage biotech company focused on developing next-generation immunomodulators by harnessing the power of glycobiology to alleviate chronic, non-resolving inflammation, announced today the formation of its European Clinical Advisory Board (CAB) made up of top internationally recognized thought leaders in retina to provide strategic consultation on the company’s clinical development of its lead asset, AVD-104, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
  • The Company also announced that Tarek S. Hassan, MD will serve as Chair of the European and US CABs.
  • “We are excited that results from Part 1 of the US Phase 2/3 SIGLEC trial demonstrated functional and anatomic improvement in eyes with GA secondary to AMD after a single injection of AVD-104,” said Mohamed Genead, M.D., Aviceda’s Co-founder and CEO.
  • “With the contributions and support of this esteemed panel—and with Dr. Hassan as its chair—we look forward to bringing our clinical efforts to Europe later this year.”

Queen's University Belfast and MOBILion Announce Collaboration to Advance Food Safety

Retrieved on: 
Thursday, March 14, 2024
QUB, Organization, PFAS, Communication, Partnership, Public, Research, Biology, Food security, Food, Mass spectrometry, Mycotoxin, Agilent Technologies, Queen's University Belfast, Food safety, School, Pharmaceutical industry

CHADDS FORD, Pa., March 14, 2024 /PRNewswire/ -- Queen's University Belfast (QUB) and MOBILion Systems, Inc. have launched a partnership to advance food safety by innovating test methods and tools that aim to quickly identify contaminants, enhancing current technologies for better detection.

Key Points: 
  • CHADDS FORD, Pa., March 14, 2024 /PRNewswire/ -- Queen's University Belfast (QUB) and MOBILion Systems, Inc. have launched a partnership to advance food safety by innovating test methods and tools that aim to quickly identify contaminants, enhancing current technologies for better detection.
  • The goal is to ensure consumer access to safe, nutritious food, highlighting both organizations' commitment to public health.
  • Their work focuses on improving the detection of contaminants such as mycotoxins and PFAS, leveraging QUB's extensive sample libraries and expertise to set new standards in food safety testing.
  • This will significantly enhance our food security research within the Institute for Global Food Security, Queen's University Belfast.

Queen's University Belfast and MOBILion Announce Collaboration to Advance Food Safety

Retrieved on: 
Thursday, March 14, 2024
QUB, Organization, PFAS, Communication, Partnership, Public, Research, Biology, Food security, Food, Mass spectrometry, Mycotoxin, Agilent Technologies, Queen's University Belfast, Food safety, School, Pharmaceutical industry

CHADDS FORD, Pa., March 14, 2024 /PRNewswire/ -- Queen's University Belfast (QUB) and MOBILion Systems, Inc. have launched a partnership to advance food safety by innovating test methods and tools that aim to quickly identify contaminants, enhancing current technologies for better detection.

Key Points: 
  • CHADDS FORD, Pa., March 14, 2024 /PRNewswire/ -- Queen's University Belfast (QUB) and MOBILion Systems, Inc. have launched a partnership to advance food safety by innovating test methods and tools that aim to quickly identify contaminants, enhancing current technologies for better detection.
  • The goal is to ensure consumer access to safe, nutritious food, highlighting both organizations' commitment to public health.
  • Their work focuses on improving the detection of contaminants such as mycotoxins and PFAS, leveraging QUB's extensive sample libraries and expertise to set new standards in food safety testing.
  • This will significantly enhance our food security research within the Institute for Global Food Security, Queen's University Belfast.

Gemstar's Rotomolded Acetal Fuel Tanks are Viable Alternative to Fluorinated HDPE Tanks

Retrieved on: 
Monday, March 4, 2024
Other Manufacturing, Technology, Packaging, Engineering, Chemicals, Plastics, Other Technology, Automotive Manufacturing, Aerospace, Manufacturing, OEM, Original equipment manufacturer, Rotation, HDPE, Heat, PFAS, EPA, Acetal, Gemstar–TV Guide International, Nylon 6, Queen's University Belfast

Rotomolded fuel tanks made of acetal, produced via Gemstar Manufacturing’s Robomold® robotic rotomolding technology, have been identified as a highly viable alternative to fluorinated fuel tanks in the wake of an Environmental Protection Agency (EPA) decision to halt the production of fluorinated coatings for HDPE containers due to PFAS contamination.

Key Points: 
  • Rotomolded fuel tanks made of acetal, produced via Gemstar Manufacturing’s Robomold® robotic rotomolding technology, have been identified as a highly viable alternative to fluorinated fuel tanks in the wake of an Environmental Protection Agency (EPA) decision to halt the production of fluorinated coatings for HDPE containers due to PFAS contamination.
  • As a fluorination-free solution, Gemstar has commercialized several EPA-certified acetal fuel tanks made with its unique Robomold® robotic rotomolding process.
  • Rotomolded acetal fuel tanks provide single-layer barrier protection that meets EPA requirements in comparison to injection molded HDPE tanks that require fluorination.
  • Acetal has previously been used in injection molded fuel tanks but material suppliers have now developed new rotomolding grades that incorporate additive packages that raise the heat performance.

NARXOZ ENTERS HISTORIC DEGREE PARTNERSHIP WITH LEADING UK UNIVERSITY

Retrieved on: 
Friday, January 26, 2024
Student, Russell Group, Bachelor, University, Republic, Employment, Research, Partnership, State, Bachelor of Business Administration, Business administration, History, Queen's University Belfast, Double degree, Education, Smith School of Business, Queen, Business school, Export, Narxoz University, Tutoring

Provides Narxoz students with access to Queen's University Belfast, a leading UK institution

Key Points: 
  • Provides Narxoz students with access to Queen's University Belfast, a leading UK institution
    ALMATY, Kazakhstan, Jan. 26, 2024 /PRNewswire/ -- Narxoz University , a preeminent private university in Almaty in the Republic of Kazakhstan, has entered into a historic Institutional Partnership and Double Degree Agreement with Queen's University Belfast, a prestigious Russell Group UK university.
  • As part of the Double Degree program, Narxoz students can receive a degree (BSc Business Management, BSc Business Economics or BSc Finance) from Queen's, a degree (Bachelor of Business Administration) from Narxoz University and the opportunity to undertake internships and employment with British companies.
  • Narxoz has become the first university in Kazakhstan and Central Asia to form an institutional partnership with Queen's University Belfast.
  • Ravishankar, Dean, Queen's Business School, Queen's University Belfast commented: "Queen's Business School looks forward to partnering with Narxoz University and building valuable relationships in Kazakhstan.

NARXOZ ENTERS HISTORIC DEGREE PARTNERSHIP WITH LEADING UK UNIVERSITY

Retrieved on: 
Friday, January 26, 2024
Student, Russell Group, Bachelor, University, Republic, Employment, Research, Multimedia, Partnership, State, Bachelor of Business Administration, Business administration, History, Queen's University Belfast, Double degree, Education, Smith School of Business, Queen, Business school, Export, Narxoz University, Tutoring

Provides Narxoz students with access to Queen's University Belfast, a leading UK institution

Key Points: 
  • Provides Narxoz students with access to Queen's University Belfast, a leading UK institution
    ALMATY, Kazakhstan, Jan. 26, 2024 /PRNewswire/ -- Narxoz University , a preeminent private university in Almaty in the Republic of Kazakhstan, has entered into a historic Institutional Partnership and Double Degree Agreement with Queen's University Belfast, a prestigious Russell Group UK university.
  • As part of the Double Degree program, Narxoz students can receive a degree (BSc Business Management, BSc Business Economics or BSc Finance) from Queen's, a degree (Bachelor of Business Administration) from Narxoz University and the opportunity to undertake internships and employment with British companies.
  • Narxoz has become the first university in Kazakhstan and Central Asia to form an institutional partnership with Queen's University Belfast.
  • Ravishankar, Dean, Queen's Business School, Queen's University Belfast commented: "Queen's Business School looks forward to partnering with Narxoz University and building valuable relationships in Kazakhstan.

ITRI and 6G-SANDBOX Signs MoU to Propel 6G Innovations

Retrieved on: 
Tuesday, November 21, 2023
Director general, Keysight, Research, ITRI, University of Oulu, Industrial Technology Research Institute, Telecommunications, Artificial intelligence, RIS, OWO, RAN, Ecosystem, Memorandum of understanding, University, Science, Queen's University Belfast, ITIS, ICT, Reality Lab, Partnership, Software engineering, Telefónica, Mobile phone, Eurescom, Lenovo

Delving into 6G research domains, ITRI and 6G-SANDBOX will focus on areas such as joint communications and sensing (JCAS) and reconfigurable intelligent surfaces (RIS).

Key Points: 
  • Delving into 6G research domains, ITRI and 6G-SANDBOX will focus on areas such as joint communications and sensing (JCAS) and reconfigurable intelligent surfaces (RIS).
  • Functioning as a vital catalyst within the Taiwanese ecosystem, ITRI will proactively engage companies in the MoU.
  • To commemorate the initiation of this collaboration, ITRI representatives visited the 6G-SANDBOX testbed in Malaga on November 8.
  • "During our visit to Gothenburg for the EuCNC & 6G Summit this year, ITRI collaborated closely with leading lights in the 6G academia and industry.

Global Platform Study Presents Results to Guide Care of Severely Ill Patients With COVID-19 Using Routinely Available Drugs – Simvastatin and Vitamin C

Retrieved on: 
Wednesday, October 25, 2023
Science, Research, Pharmaceutical, Health, COVID-19, Infectious Diseases, Hospitals, Clinical Trials, WHO, Urinary tract infection, Survival, FRCP, Patient, Vitamin C, Simvastatin, Royal Victoria Hospital, Montreal, Bronchopneumonia, MPH, Global Coalition Against Pneumonia, Oregon Health & Science University, University, Respiratory tract infection, JAMA, Professor, Vitamin, Multimedia, Queen's University Belfast, University of Pittsburgh School of Medicine, Learning, Critical Care Medicine (journal), COVID, Clinical trial, Intensive care unit, Hospital, NEJM, Probability, Pittsburgh, European Society of Clinical Microbiology and Infectious Diseases, Wilfrid Sellars, SUNY Downstate Health Sciences University, Hospice and palliative medicine, Intensive care medicine, Royal Victoria Hospital, UPMC, Consultant, Ohio State University Wexner Medical Center, Pharmaceutical industry, Dietary supplement, MD

Vitamin C is widely available around the world and was used in some settings for the treatment of COVID-19.

Key Points: 
  • Vitamin C is widely available around the world and was used in some settings for the treatment of COVID-19.
  • Through harmonizing two clinical trials – REMAP-CAP and LOVIT-COVID – over 2500 patients in 20 countries took part, including both critically ill and non-critically ill patients with COVID-19 in hospital.
  • It was shown that high dose vitamin C did not improve outcomes for patients.
  • Intravenous Vitamin C for Patients Hospitalized with COVID-19: Two Harmonized Randomized Clinical Trials.

Options Announces 200 New Jobs in Belfast, Expanding its Flagship City Centre Office

Retrieved on: 
Thursday, September 14, 2023
Professional Services, Data Management, Technology, Finance, Software, Fintech, Cloud, Workforce, Heart, Learning, Partnership, Placement, Belfast Metropolitan College, Microsoft, Multimedia, History, The National, Queen's University Belfast, Graduate, Student, Belfast City Centre, Investment, Engineering, Ulster University, AI, News, Management, Nursing, Creative industries, Option

The rapidly growing company, headquartered in the heart of Belfast City Centre's Linen Loft building, is making significant strides in expanding its operations.

Key Points: 
  • The rapidly growing company, headquartered in the heart of Belfast City Centre's Linen Loft building, is making significant strides in expanding its operations.
  • The company remains steadfast in its focus on recruiting high-quality graduates and engineering professionals, strengthening its ties with local academic institutions.
  • Danny Moore , President and CEO of Options, commented, "Our decision to expand our workforce in Belfast reflects the exceptional talent we've found in this vibrant city.
  • This investment enabled Options to accelerate its growth strategy and develop its technology platform while expanding its global reach in key financial centres.

Parenteral Drug Association Announces Pulitzer Prize Winner Dominic Gates will speak at the 2023 PDA/FDA Joint Regulatory Conference

Retrieved on: 
Friday, September 1, 2023
Mathematics, Boeing, The Seattle Times, DC, Business, Parenteral Drug Association, E. W. Scripps Company, MAX, Science, PDA, Queen's University Belfast, Amazon, Pure mathematics, George Polk, Pulitzer Prize, Patient, Crash, Gates, Conference, Pharmaceutical industry

BETHESDA, Md., Sept. 1, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association, Inc. (PDA), today announced Pulitzer Prize winning journalist Dominic Gates of the Seattle Times will present, "The Devastating Impact of Design and Manufacturing Quality Lapses at Boeing" during the second plenary session of the 2023 PDA/FDA Joint Regulatory Conference in Washington, DC, Sept. 18-20.

Key Points: 
  • BETHESDA, Md., Sept. 1, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association, Inc. (PDA), today announced Pulitzer Prize winning journalist Dominic Gates of the Seattle Times will present, "The Devastating Impact of Design and Manufacturing Quality Lapses at Boeing" during the second plenary session of the 2023 PDA/FDA Joint Regulatory Conference in Washington, DC, Sept. 18-20.
  • PDA is very excited to have Mr. Gates join us at the 2023 PDA/FDA Joint Regulatory Conference to share such a compelling, although tragic, case-study on the life-and-death outcomes that poor quality practices and decisions can have.
  • Gates was a co-recipient of the 2020 Pulitzer Prize in National Reporting alongside Steve Miletich, Mike Baker, and Lewis Kamb for their coverage of the Boeing 737 MAX crashes and investigations.
  • For more information on the 2023 PDA/FDA Joint Regulatory Conference,